Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.44
MCK's Cash to Debt is ranked higher than
62% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.47 vs. MCK: 0.44 )
MCK' s 10-Year Cash to Debt Range
Min: 0.05   Max: 3.01
Current: 0.44

0.05
3.01
Equity to Asset 0.17
MCK's Equity to Asset is ranked higher than
51% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.41 vs. MCK: 0.17 )
MCK' s 10-Year Equity to Asset Range
Min: 0.17   Max: 0.35
Current: 0.17

0.17
0.35
Interest Coverage 7.81
MCK's Interest Coverage is ranked higher than
57% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.68 vs. MCK: 7.81 )
MCK' s 10-Year Interest Coverage Range
Min: 0.94   Max: 12.77
Current: 7.81

0.94
12.77
F-Score: 6
Z-Score: 4.43
M-Score: -2.30
WACC vs ROIC
6.73%
14.03%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 1.60
MCK's Operating margin (%) is ranked higher than
57% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.54 vs. MCK: 1.60 )
MCK' s 10-Year Operating margin (%) Range
Min: -0.27   Max: 2.54
Current: 1.6

-0.27
2.54
Net-margin (%) 0.99
MCK's Net-margin (%) is ranked higher than
57% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.41 vs. MCK: 0.99 )
MCK' s 10-Year Net-margin (%) Range
Min: -0.2   Max: 4.29
Current: 0.99

-0.2
4.29
ROE (%) 19.68
MCK's ROE (%) is ranked higher than
89% of the 63 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.17 vs. MCK: 19.68 )
MCK' s 10-Year ROE (%) Range
Min: -3.01   Max: 22.45
Current: 19.68

-3.01
22.45
ROA (%) 3.45
MCK's ROA (%) is ranked higher than
63% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.22 vs. MCK: 3.45 )
MCK' s 10-Year ROA (%) Range
Min: -0.9   Max: 7.46
Current: 3.45

-0.9
7.46
ROC (Joel Greenblatt) (%) 86.86
MCK's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.99 vs. MCK: 86.86 )
MCK' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -7.04   Max: 196.7
Current: 86.86

-7.04
196.7
Revenue Growth (3Y)(%) 11.50
MCK's Revenue Growth (3Y)(%) is ranked higher than
75% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. MCK: 11.50 )
MCK' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: 26.5
Current: 11.5

0
26.5
EBITDA Growth (3Y)(%) 14.20
MCK's EBITDA Growth (3Y)(%) is ranked higher than
75% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.90 vs. MCK: 14.20 )
MCK' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 171.6
Current: 14.2

0
171.6
EPS Growth (3Y)(%) 10.80
MCK's EPS Growth (3Y)(%) is ranked higher than
69% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.10 vs. MCK: 10.80 )
MCK' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 87.1
Current: 10.8

0
87.1
» MCK's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

MCK Guru Trades in Q1 2014

John Burbank 1,302 sh (New)
Mario Gabelli 11,520 sh (New)
Joel Greenblatt 44,157 sh (+106.75%)
Pioneer Investments 402,758 sh (+97.89%)
Leon Cooperman 710,982 sh (+2.52%)
Jim Simons Sold Out
Andreas Halvorsen Sold Out
Vanguard Health Care Fund 7,343,200 sh (-1.43%)
Scott Black 63,383 sh (-6.95%)
Larry Robbins 2,408,550 sh (-21.06%)
Ray Dalio 31,030 sh (-45.21%)
Steven Cohen 12,995 sh (-86.62%)
Paul Tudor Jones 1,300 sh (-95.44%)
Jeremy Grantham 9,600 sh (-97.19%)
» More
Q2 2014

MCK Guru Trades in Q2 2014

Lee Ainslie 1,719,923 sh (New)
Jim Simons 461,900 sh (New)
Paul Tudor Jones 79,317 sh (+6001.31%)
Mario Gabelli 14,560 sh (+26.39%)
Larry Robbins 2,837,666 sh (+17.82%)
Pioneer Investments 465,693 sh (+15.63%)
Larry Robbins 250,000 sh (unchged)
Steven Cohen 301,500 sh (unchged)
John Burbank Sold Out
Jeremy Grantham 9,200 sh (-4.17%)
Leon Cooperman 669,775 sh (-5.80%)
Vanguard Health Care Fund 6,584,000 sh (-10.34%)
Scott Black 44,542 sh (-29.73%)
Joel Greenblatt 20,104 sh (-54.47%)
Ray Dalio 4,030 sh (-87.01%)
» More
Q3 2014

MCK Guru Trades in Q3 2014

Louis Moore Bacon 40,000 sh (New)
Jeremy Grantham 227,600 sh (+2373.91%)
Ray Dalio 17,713 sh (+339.53%)
Lee Ainslie 1,857,273 sh (+7.99%)
Pioneer Investments 464,393 sh (unchged)
Joel Greenblatt Sold Out
Leon Cooperman 652,175 sh (-2.63%)
Scott Black 43,133 sh (-3.16%)
Mario Gabelli 14,040 sh (-3.57%)
Vanguard Health Care Fund 6,342,800 sh (-3.66%)
Larry Robbins 1,866,966 sh (-34.21%)
Paul Tudor Jones 50,000 sh (-36.96%)
Jim Simons 161,100 sh (-65.12%)
Steven Cohen 85,100 sh (-71.77%)
» More
Q4 2014

MCK Guru Trades in Q4 2014

Ken Fisher 967 sh (New)
Ray Dalio 22,313 sh (+25.97%)
Mario Gabelli 17,490 sh (+24.57%)
Leon Cooperman 715,203 sh (+9.66%)
Vanguard Health Care Fund 6,342,800 sh (unchged)
Louis Moore Bacon Sold Out
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
Jim Simons Sold Out
Pioneer Investments 463,990 sh (-0.09%)
Scott Black 38,844 sh (-9.94%)
Larry Robbins 1,352,460 sh (-27.56%)
Lee Ainslie 1,307,419 sh (-29.61%)
Steven Cohen 15,000 sh (-82.37%)
» More
» Details

Insider Trades

Latest Guru Trades with MCK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about McKesson Corp

Leon Cooperman's Top Growth Stocks
Leon Cooperman (Trades, Portfolio)'s firm Omega Advisors is one of the largest hedge funds that has maintained a quarter over quarter turnover around 17%. Even in 2008 during the financial crisis, Cooperman was able to beat the market by staying away from the financial stocks. Read more...
Weekly Insider Sells Highlight: HCA, MCK, P, ROP
According to GuruFocus Insider Data, the largest insider sells during the past week were: HCA Holdings Inc., McKesson Corp, Pandora Media Inc. and Roper Industries Inc. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 31.40
MCK's P/E(ttm) is ranked higher than
68% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.90 vs. MCK: 31.40 )
MCK' s 10-Year P/E(ttm) Range
Min: 8.15   Max: 37.78
Current: 31.4

8.15
37.78
Forward P/E 18.35
MCK's Forward P/E is ranked higher than
86% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.87 vs. MCK: 18.35 )
N/A
PE(NRI) 30.90
MCK's PE(NRI) is ranked higher than
68% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.90 vs. MCK: 30.90 )
MCK' s 10-Year PE(NRI) Range
Min: 8.17   Max: 35.07
Current: 30.9

8.17
35.07
P/B 5.80
MCK's P/B is ranked higher than
54% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.73 vs. MCK: 5.80 )
MCK' s 10-Year P/B Range
Min: 1.29   Max: 5.87
Current: 5.8

1.29
5.87
P/S 0.30
MCK's P/S is ranked higher than
88% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.91 vs. MCK: 0.30 )
MCK' s 10-Year P/S Range
Min: 0.08   Max: 0.32
Current: 0.3

0.08
0.32
PFCF 16.00
MCK's PFCF is ranked higher than
88% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 59.38 vs. MCK: 16.00 )
MCK' s 10-Year PFCF Range
Min: 4.69   Max: 41.74
Current: 16

4.69
41.74
POCF 13.59
MCK's POCF is ranked higher than
78% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.62 vs. MCK: 13.59 )
MCK' s 10-Year POCF Range
Min: 4.25   Max: 88.45
Current: 13.59

4.25
88.45
EV-to-EBIT 20.99
MCK's EV-to-EBIT is ranked higher than
70% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.05 vs. MCK: 20.99 )
MCK' s 10-Year EV-to-EBIT Range
Min: -118.3   Max: 23.1
Current: 20.99

-118.3
23.1
PEG 1.90
MCK's PEG is ranked higher than
89% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 53.67 vs. MCK: 1.90 )
MCK' s 10-Year PEG Range
Min: 0.16   Max: 4.79
Current: 1.9

0.16
4.79
Shiller P/E 40.80
MCK's Shiller P/E is ranked higher than
70% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 40.56 vs. MCK: 40.80 )
MCK' s 10-Year Shiller P/E Range
Min: 12.57   Max: 42.43
Current: 40.8

12.57
42.43
Current Ratio 1.13
MCK's Current Ratio is ranked lower than
51% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.52 vs. MCK: 1.13 )
MCK' s 10-Year Current Ratio Range
Min: 1.08   Max: 1.71
Current: 1.13

1.08
1.71
Quick Ratio 0.66
MCK's Quick Ratio is ranked lower than
51% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.03 vs. MCK: 0.66 )
MCK' s 10-Year Quick Ratio Range
Min: 0.52   Max: 0.94
Current: 0.66

0.52
0.94
Days Inventory 30.66
MCK's Days Inventory is ranked higher than
86% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 53.46 vs. MCK: 30.66 )
MCK' s 10-Year Days Inventory Range
Min: 30.32   Max: 44.87
Current: 30.66

30.32
44.87
Days Sales Outstanding 34.81
MCK's Days Sales Outstanding is ranked higher than
84% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.12 vs. MCK: 34.81 )
MCK' s 10-Year Days Sales Outstanding Range
Min: 18.94   Max: 33.27
Current: 34.81

18.94
33.27

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.40
MCK's Dividend Yield is ranked lower than
90% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. MCK: 0.40 )
MCK' s 10-Year Dividend Yield Range
Min: 0.35   Max: 1.42
Current: 0.4

0.35
1.42
Dividend Payout 0.13
MCK's Dividend Payout is ranked higher than
97% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.60 vs. MCK: 0.13 )
MCK' s 10-Year Dividend Payout Range
Min: 0.04   Max: 6
Current: 0.13

0.04
6
Dividend growth (3y) 8.50
MCK's Dividend growth (3y) is ranked higher than
65% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.40 vs. MCK: 8.50 )
MCK' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 44.2
Current: 8.5

0
44.2
Yield on cost (5-Year) 0.80
MCK's Yield on cost (5-Year) is ranked lower than
88% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.91 vs. MCK: 0.80 )
MCK' s 10-Year Yield on cost (5-Year) Range
Min: 0.7   Max: 2.86
Current: 0.8

0.7
2.86
Share Buyback Rate 4.00
MCK's Share Buyback Rate is ranked higher than
91% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.20 vs. MCK: 4.00 )
MCK' s 10-Year Share Buyback Rate Range
Min: 0   Max: -43.4
Current: 4

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.40
MCK's Price/DCF (Projected) is ranked higher than
85% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.82 vs. MCK: 1.40 )
MCK' s 10-Year Price/DCF (Projected) Range
Min: 0.55   Max: 17.04
Current: 1.4

0.55
17.04
Price/Median PS Value 1.70
MCK's Price/Median PS Value is ranked higher than
57% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. MCK: 1.70 )
MCK' s 10-Year Price/Median PS Value Range
Min: 0.01   Max: 4.22
Current: 1.7

0.01
4.22
Price/Peter Lynch Fair Value 2.30
MCK's Price/Peter Lynch Fair Value is ranked higher than
85% of the 74 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.00 vs. MCK: 2.30 )
MCK' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.34   Max: 72.67
Current: 2.3

0.34
72.67
Earnings Yield (Greenblatt) 4.70
MCK's Earnings Yield (Greenblatt) is ranked higher than
69% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.80 vs. MCK: 4.70 )
MCK' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.3   Max: 16.5
Current: 4.7

4.3
16.5
Forward Rate of Return (Yacktman) 17.72
MCK's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.54 vs. MCK: 17.72 )
MCK' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -49.4   Max: 102.1
Current: 17.72

-49.4
102.1

Analyst Estimate

Mar15 Mar16 Mar17
Revenue(Mil) 179,200 188,302 198,521
EPS($) 10.46 12.48 15.18
EPS without NRI($) 10.46 12.48 15.18

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, CAH, SHTDF, HSIC, PDCO » details
Traded in other countries:MCK.Germany, MCK.Mexico,
McKesson Corporation is a Delaware Corporation. The Company delivers pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment and health and beauty care products throughout North America and internationally. This segment provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. This segment also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers through a network of distribution centers within the U.S. In addition, this segment sells financial, operational and clinical solutions for pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services. The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes its InterQual clinical criteria solution, claims payment solutions and network performance tools. This segment also delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. This segment's customers include hospitals, physicians, homecare providers, retail pharmacies and payers primarily from North America. McKesson Distribution Solutions consists of the following businesses: North America pharmaceutical distribution and services, International pharmaceutical distribution and services and Medical Surgical distribution and services. The Company competes with other software services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, payers, care management organizations, hardware vendors and internet-based companies with technology applicable to the healthcare industry.
» More Articles for MCK

Headlines

Articles On GuruFocus.com
Larry Robbins' Top Growth Stocks Mar 25 2015 
Leon Cooperman's Top Growth Stocks Mar 22 2015 
Rite Aid Corporation is a Buy Feb 19 2015 
Manson Creek Terminates Option on Uptown Gold Property, NWT Dec 22 2014 
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
A Few Reasons Why McKesson Could Be a Good Investment Dec 11 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
CPSI: A Predictable And Undervalued Small Cap Dec 05 2014 
Rite Aid Corporation Looks Promising Dec 05 2014 
McKesson's Growth Is Set to Continue in the Long Run Nov 25 2014 

More From Other Websites
McKesson Stock: 3 Reasons Why It Is a Top Choice for Growth Investors - Tale of the Tape Mar 31 2015
McKesson Provides Illinois Radiology Group with Revenue Cycle, Financial Management Assistance Mar 30 2015
McKesson Helps Stabilize Billing for Michigan Radiology Group Mar 24 2015
Stocks Off To A Twitchy Start; Netflix, Twitter, Merck Surge Mar 24 2015
DENTSPLY: Product Portfolio Strong, Currency Woes Remain - Analyst Blog Mar 19 2015
CONMED: Strong Sell on Dismal Q4 Results, Estimate Revision - Analyst Blog Mar 18 2015
LabCorp Boosts Specialty Testing with Two New Studies - Analyst Blog Mar 16 2015
Invacare Cut to Strong Sell on Dismal Q4, Should You Dump? - Analyst Blog Mar 12 2015
McKesson Canada appoints Richard Brennan as new Senior Vice President, Retail Banner Management... Mar 11 2015
McKesson Care Management Awarded NCQA Accreditation for Case Management Mar 05 2015
STAAR Surgical Reports Loss in Q4, Appoints New CEO - Analyst Blog Mar 05 2015
Arizona Oncology Reminds Men and Women to Get Screened for Colorectal Cancer Mar 02 2015
The CIO Leads Innovation And Purchasing At $8 Billion Ferrovial Mar 02 2015
McKesson Appoints Bansi Nagji to Executive Vice President of Corporate Strategy and Business... Feb 26 2015
McKesson Honored as a ‘Best Place to Work’ for Second Year in a Row by Human Rights Campaign... Feb 26 2015
Eight Health Plans Choose McKesson’s Network Management Solutions Feb 25 2015
These 5 Big Caps Hit New Closing Highs Feb 25 2015
Express Scripts (ESRX) Beats on Q4 Earnings & Revenues - Analyst Blog Feb 24 2015
Monday's Market Recap Feb 23 2015
LabCorp Beats Q4 Earnings, Positive on Covance Addition - Analyst Blog Feb 20 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK